Verve Therapeutics Inc 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
Krishna Yeshwant | 4 | 1,587,538 |
Gv 2017 Gp, L.l.c. | 3 | -424,925 |
Allison Dorval | 2 | -1,108 |
Andrew Bellinger | 2 | -10,865 |
Sekar Kathiresan | 1 | -50,000 |
Joan Nickerson | 1 | -1,514 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 0 | 0 |
最近3个月 | 0 | 1,514 | -1,514 |
最近6个月 | 1,800,000 | 2,068 | 1,797,932 |
最近12个月 | 1,800,000 | 2,068 | 1,797,932 |
最近18个月 | 1,800,000 | 3,487 | 1,796,513 |
最近36个月 | 1,800,000 | 760,874 | 1,039,126 |
Verve Therapeutics Inc 内部交易
Verve Therapeutics Inc 最新内部交易
Joan Nickerson | Chief Administrative Officer | 2024-04-02 | 卖出 | 1,514 | 8,659 |
$8.24
|
-22.21%
|
Krishna Yeshwant | Director, 10% Owner | 2023-12-01 | 买入 | 1,800,000 | 12,168,489 |
$10
|
-35.90%
|
Allison Dorval | CFO | 2023-11-29 | 卖出 | 554 | 4,060 |
$11.45
|
-44.02%
|
Andrew Bellinger | CSO & CMO | 2022-12-01 | 卖出 | 865 | 6,629 |
$22.95
|
-72.07%
|
Allison Dorval | CFO | 2022-11-29 | 卖出 | 554 | 2,186 |
$22.1
|
-71.00%
|
Gv 2017 Gp, L.l.c. | - | 2022-11-04 | 卖出 | 97,166 | 10,368,489 |
$31.14
|
-79.42%
|
Krishna Yeshwant | Director, 10% Owner | 2022-11-04 | 卖出 | 48,583 | 10,368,489 |
$31.14
|
-79.42%
|
Krishna Yeshwant | Director, 10% Owner | 2022-11-03 | 卖出 | 78,220 | 10,465,655 |
$33.95
|
-81.12%
|
Gv 2017 Gp, L.l.c. | - | 2022-11-03 | 卖出 | 156,440 | 10,465,655 |
$33.95
|
-81.12%
|
Gv 2017 Gp, L.l.c. | - | 2022-11-01 | 卖出 | 171,319 | 10,622,095 |
$37.95
|
-83.11%
|